These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 8539827)

  • 1. FK 506-based immunosuppression in clinical pancreas transplantation.
    Swanson C; Rubin M; Colquhoun S; Basadonna G; Asshinnik A; Perez R
    Transplant Proc; 1995 Dec; 27(6):3031. PubMed ID: 8539827
    [No Abstract]   [Full Text] [Related]  

  • 2. FK 506 induction and rescue therapy in pancreas transplant recipients.
    Stratta RJ; Taylor RJ; Castaldo P; Sindhi R; Sudan D; Weide LG; Frisbie K; Cushing KA; Jerius J; Radio SJ
    Transplant Proc; 1996 Apr; 28(2):991-2. PubMed ID: 8623492
    [No Abstract]   [Full Text] [Related]  

  • 3. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.
    Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO
    Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494
    [No Abstract]   [Full Text] [Related]  

  • 4. Tacrolimus-based vs cyclosporine-based immunotherapy in combined kidney-pancreas transplantation.
    Ketel BL; Turton-Weeks S; Reed K; Barone GW
    Transplant Proc; 1996 Apr; 28(2):899. PubMed ID: 8623453
    [No Abstract]   [Full Text] [Related]  

  • 5. Outcome of monoclonal antibody induction and anti-rejection therapy in pancreas transplantation.
    Bruce DS; Newell KA; Woodle ES; Millis JM; Piper JB; Huss E; Thistlethwaite JR
    Transplant Proc; 1996 Aug; 28(4):2136-7. PubMed ID: 8769180
    [No Abstract]   [Full Text] [Related]  

  • 6. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
    Schulz T; Kapischke M; Busing M
    Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.
    Woodle ES; Thistlethwaite JR; Haas M; Josephson MA; Newell KA; Bruce DS; Millis JM; Piper JB; Charette JI
    Transplant Proc; 1996 Apr; 28(2):998-9. PubMed ID: 8623495
    [No Abstract]   [Full Text] [Related]  

  • 8. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
    Nashan B
    Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporin monotherapy in pancreaticorenal transplantation.
    Ward RG; Gecim E; Bone JM; Bakran A; Sells RA
    Transplant Proc; 1994 Apr; 26(2):548. PubMed ID: 8171547
    [No Abstract]   [Full Text] [Related]  

  • 10. Triple versus quadruple induction immunosuppression in pancreas transplantation.
    Wadström J; Brekke B; Wramner L; Ekberg H; Tydén G
    Transplant Proc; 1995 Feb; 27(1):1317-8. PubMed ID: 7878896
    [No Abstract]   [Full Text] [Related]  

  • 11. Preliminary experience with FK 506 in pancreas transplant recipients.
    Stratta RJ; Taylor RJ; Castaldo P; Sindhi R; Sudan D; Frisbie K; Cushing K
    Transplant Proc; 1995 Dec; 27(6):3024. PubMed ID: 8539823
    [No Abstract]   [Full Text] [Related]  

  • 12. Conversion of pancreas transplants to FK 506 from CsA.
    Tesi RJ; Bryer-Ash M; Jaspan J; Byer-Ashe M [corrected to Bryer-Ash M]
    Transplant Proc; 1995 Dec; 27(6):3032-3. PubMed ID: 8539828
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of tacrolimus versus cyclosporine in kidney and pancreas transplant recipients.
    el-Ghoroury M; Hariharan S; Peddi VR; Munda R; Schroeder TJ; Demmy AM; Alexander JW; First MR
    Transplant Proc; 1997; 29(1-2):649-51. PubMed ID: 9123461
    [No Abstract]   [Full Text] [Related]  

  • 14. Tacrolimus (FK 506) in kidney transplantation: three-year survival results of the US multicenter, randomized, comparative trial. FK 506 Kidney Transplant Study Group.
    Jensik SC
    Transplant Proc; 1998 Jun; 30(4):1216-8. PubMed ID: 9636494
    [No Abstract]   [Full Text] [Related]  

  • 15. Current advantage of FK 506 in cadaveric kidney transplantation.
    Ciancio G; Rosen A; Loreto-Grand B; Burke G; Siquijor A; Luque C; Esquenazi V; Miller J
    Transplant Proc; 1996 Apr; 28(2):1000-1. PubMed ID: 8623207
    [No Abstract]   [Full Text] [Related]  

  • 16. Reversal of accelerated renal allograft rejection with FK 506.
    Woodle ES; Newell KA; Haas M; Bartosh S; Josephson MA; Millis JM; Bruce DS; Piper JB; Aronson AJ; Thistlethwaite JR
    Clin Transplant; 1997 Aug; 11(4):251-4. PubMed ID: 9267710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients.
    Platz KP; Tullius SG; Mueller AR; Schumacher G; Nüssler N; Neuhaus R; Bechstein WO; Lobeck H; Neuhaus P
    Transplant Proc; 1996 Dec; 28(6):3183-4. PubMed ID: 8962235
    [No Abstract]   [Full Text] [Related]  

  • 18. Tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: the EURO-SPK 3-year results.
    Malaise J; Saudek F; Boucek P; Adamec M; Van Ophem D; Squifflet JP;
    Transplant Proc; 2005; 37(6):2843-5. PubMed ID: 16182828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of surgical complications after simultaneous pancreas-kidney transplantation in a prospectively randomized study of two immunosuppressive protocols.
    Steurer W; Malaise J; Mark W; Koenigsrainer A; Margreiter R;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii54-62. PubMed ID: 15814551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine therapy in pancreas transplantation.
    Davidson I; Lu C; Melone D; Risser R
    Transplant Proc; 1996 Aug; 28(4):2134-5. PubMed ID: 8769179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.